CLINICAL_TRIALS trial_result · 2010-07-13

Clinical Trial Update: Remission and Joint Damage Progression in Early Rheumatoid Arthritis [Phase 3]

Phase 3 clinical trial evaluating remission and progression of joint damage in early rheumatoid arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-07-13